
    
      Main research objectives:

      To evaluate the safety and efficacy of Senl-h19 CAR-T in patients with relapsed or refractory
      acute lymphoblastic leukemia Secondary research purpose To investigate the cytokinetic
      characteristics of Senl-h19 CAR-T in patients with relapsed or refractory acute lymphoblastic
      leukemia.
    
  